Moody Aldrich Partners LLC bought a new stake in Teladoc Health Inc (NYSE:TDOC) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 41,333 shares of the health services provider’s stock, valued at approximately $3,569,000. Moody Aldrich Partners LLC owned approximately 0.06% of Teladoc Health as of its most recent filing with the SEC.
Other institutional investors also recently modified their holdings of the company. Commonwealth Equity Services LLC raised its stake in shares of Teladoc Health by 13.0% in the 2nd quarter. Commonwealth Equity Services LLC now owns 24,464 shares of the health services provider’s stock valued at $1,420,000 after purchasing an additional 2,809 shares in the last quarter. BlackRock Inc. raised its stake in Teladoc Health by 9.0% during the second quarter. BlackRock Inc. now owns 5,318,850 shares of the health services provider’s stock worth $308,759,000 after acquiring an additional 437,136 shares during the period. Columbus Circle Investors raised its stake in Teladoc Health by 9.8% during the second quarter. Columbus Circle Investors now owns 442,488 shares of the health services provider’s stock worth $25,686,000 after acquiring an additional 39,503 shares during the period. OppenheimerFunds Inc. acquired a new stake in Teladoc Health during the second quarter worth about $20,163,000. Finally, First Republic Investment Management Inc. acquired a new stake in Teladoc Health during the second quarter worth about $465,000.
Shares of NYSE:TDOC opened at $72.51 on Friday. Teladoc Health Inc has a 52 week low of $27.30 and a 52 week high of $89.05. The company has a debt-to-equity ratio of 0.58, a quick ratio of 3.14 and a current ratio of 3.14.
Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, November 1st. The health services provider reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.36) by $0.02. Teladoc Health had a negative net margin of 37.78% and a negative return on equity of 19.10%. The company had revenue of $111.00 million for the quarter, compared to analyst estimates of $109.94 million. During the same quarter last year, the business earned ($0.55) earnings per share. Teladoc Health’s revenue was up 61.6% compared to the same quarter last year. Analysts predict that Teladoc Health Inc will post -1.49 earnings per share for the current year.
Several equities research analysts recently weighed in on TDOC shares. Cantor Fitzgerald reiterated a “hold” rating and set a $52.00 price objective on shares of Teladoc Health in a research note on Wednesday, August 1st. Wells Fargo & Co reiterated a “buy” rating and set a $70.00 price objective on shares of Teladoc Health in a research note on Thursday, August 2nd. KeyCorp increased their price objective on shares of Teladoc Health from $74.00 to $90.00 and gave the stock an “overweight” rating in a research note on Monday, August 27th. MED increased their price objective on shares of Teladoc Health from $68.00 to $89.00 and gave the stock an “outperform” rating in a research note on Friday, September 28th. Finally, Citigroup increased their price objective on shares of Teladoc Health from $80.00 to $88.00 and gave the stock a “buy” rating in a research note on Friday, September 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $82.95.
In other Teladoc Health news, insider Adam C. Vandervoort sold 5,549 shares of the firm’s stock in a transaction that occurred on Wednesday, August 8th. The shares were sold at an average price of $67.25, for a total value of $373,170.25. Following the sale, the insider now owns 2,934 shares in the company, valued at $197,311.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Lewis Levy sold 1,285 shares of the firm’s stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $70.80, for a total transaction of $90,978.00. The disclosure for this sale can be found here. Insiders sold 166,706 shares of company stock worth $12,412,229 in the last 90 days. 3.95% of the stock is owned by company insiders.
Teladoc Health Profile
Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Further Reading: Insider Trading
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.